Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial

Title:	Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial
Authors:	Fransecky, Lars^{Aff1, Aff2, IDs00277026068838_cor1}; Fiedler, Walter^Aff3; Röllig, Christoph^Aff4; Sauer, Tim^Aff5; Raffel, Simon^Aff5; Alsdorf, Winfried^Aff3; Heberling, Lisa^Aff4; Steer, Britta^{Aff1, Aff2}; Huber, Karin^{Aff1, Aff2, Aff6}; Versteegen, Tim^{Aff1, Aff2}; Spory, Lea^{Aff1, Aff2}; Deckbar, Dorothee^Aff7; Reiser, Lena^Aff7; Bendig, Sonja^{Aff1, Aff2, Aff6}; Bastian, Lorenz^{Aff1, Aff2, Aff6}; Bozzetti, Cecilia^{Aff1, Aff2}; Beder, Thomas^{Aff1, Aff2}; Neumann, Martin^{Aff1, Aff2, Aff6}; Brüggemann, Monika^{Aff1, Aff2, Aff6}; Gökbuget, Nicola^Aff7; Baldus, Claudia^{Aff1, Aff2, Aff6}
Source:	Annals of Hematology. 105(3)
Database:	Springer Nature Journals